Wolverine Trading, LLC Nymox Pharmaceutical Corp Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.84 - $2.83 $19,382 - $29,811	-10,534 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$2.3 - $3.66 $850 - $1,354	370 Added 3.64%	10,534 $27,000
Q2 2020 Aug 13, 2020	SELL	$2.1 - $4.6 $865 - $1,895	-412 Reduced 3.9%	10,164 $36,000
Q1 2020 May 11, 2020	BUY	$1.69 - $3.88 $49 - $112	29 Added 0.27%	10,576 $23,000
Q1 2019 May 15, 2019	SELL	$1.57 - $2.71 $25,215 - $43,525	-16,061 Reduced 60.36%	10,547 $21,000
Q4 2018 Feb 14, 2019	SELL	$1.31 - $2.53 $30,524 - $58,951	-23,301 Reduced 46.69%	26,608 $38,000
Q3 2018 Nov 14, 2018	BUY	$2.46 - $3.7 $18,946 - $28,497	7,702 Added 18.25%	49,909 $123,000
Q1 2018 May 15, 2018	SELL	$3.09 - $4.43 $60,202 - $86,309	-19,483 Reduced 31.58%	42,207 $179,000
Q4 2017 Feb 14, 2018	SELL	$3.29 - $4.06 $31,278 - $38,598	-9,507 Reduced 13.35%	61,690 $204,000
Q3 2017 Nov 15, 2017	BUY	$3.36 - $4.02 $239,221 - $286,211	71,197	71,197 $272,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.